Latest news with #roboticsurgery
Yahoo
5 days ago
- Business
- Yahoo
ISRG: Solid Numbers, Tariff Concerns
Key Points Intuitive Surgical posted a strong quarter, topping expectations on 20%-plus revenue and earnings growth. The company's latest-generation systems are continuing to gain traction. Intuitive sounded a cautious outlook about the quarters ahead due to tariff uncertainty. 10 stocks we like better than Intuitive Surgical › Here's our initial take on Intuitive Surgical's (NASDAQ: ISRG) financial report. Key Metrics Metric Q2 2024 Q2 2025 Change vs. Expectations Revenue $2.01 billion $2.44 billion 20% Beat Adjusted EPS $1.78 $2.19 23% Beat Da Vinci systems placed 341 395 16% n/a Da Vinci total installed systems 9,203 10,488 14% n/a Intuitive Momentum Remains Strong Robotic surgery pioneer Intuitive Surgical posted another solid quarterly beat, growing revenue by 20% and earnings per share by 23% in the most recent quarter. The company continues to see strong demand for its machines and strong usage once they are installed, driving a beat. The company placed 395 of its da Vinci systems in the quarter, up 16% from a year ago, and the number of high-end da Vinci 5 systems more than doubled to 180. At the end of the quarter, Intuitive had an installed base of 10,488 systems, up from 9,203 a year ago. Worldwide procedures grew by 17%, a good sign for a company that sells not just the new systems but disposable equipment needed on a per-surgery basis. The company ended the second quarter of 2025 with $9.53 billion in cash, up $431 million during the quarter, driven by cash generated from operations. Immediate Market Reaction Though the quarter was strong, there are some questions about how tariffs would impact the company in the quarters ahead. Intuitive share prices were down about 4% in after-market trading following the release but ahead of the company's call with investors. What to Watch Intuitive does not expect that 17% procedure growth to sustain into the second half. For the full year, the company forecasts procedure growth of about 15.5% to 17%, compared to 17% in the quarter and all of last year. Operating expenses are also expected to climb by 10% to 14% for the year, compared to 10% in 2024. Intuitive said the updated expectation "reflects the company's estimates of the adverse impact from tariffs that are currently in effect as of the time of this press release and assumes such tariffs remain in place." The company continues to push the envelope, during the quarter conducting a telesurgery demonstration in which doctors in Georgia and France operated a dual-console da Vinci 5 system to simulate a procedure. Those sorts of innovations promise to both allow more patients to benefit from the systems and open up new potential markets for the company. Intuitive remains on the path for growth, but near-term tariff headwinds are likely to continue to cloud the picture in the quarters to come. Helpful Resources Full earnings report Investor relations page Additional coverage Should you invest $1,000 in Intuitive Surgical right now? Before you buy stock in Intuitive Surgical, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the for investors to buy now… and Intuitive Surgical wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $641,800!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,023,813!* Now, it's worth noting Stock Advisor's total average return is 1,034% — a market-crushing outperformance compared to 180% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of July 21, 2025 Lou Whiteman has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Intuitive Surgical. The Motley Fool has a disclosure policy. ISRG: Solid Numbers, Tariff Concerns was originally published by The Motley Fool Error in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
13-07-2025
- Business
- Yahoo
FDA Approves Intuitive Surgical's (ISRG) New Vessel Sealer Tool
Intuitive Surgical, Inc. (NASDAQ:ISRG) is one of the 13 Best Large Cap Stocks to Buy Right Now. On July 10, Intuitive Surgical, Inc. (NASDAQ:ISRG) reported that it has received approval from the US Food & Drug Administration (FDA) for its latest innovation in advanced energy tools for use with its multiport da Vinci systems. This new tool, called the Vessel Sealer Curved, is a fully wristed, advanced bipolar electrosurgical instrument that can seal, cut, grasp, and dissect tissue. This instrument is the first of Intuitive Surgical, Inc.'s (NASDAQ:ISRG) advanced energy instruments to get FDA approval for the transection of lymphatic vessels. A medical team performing minimally invasive surgery with a da Vinci Surgical System. Vessel Sealer Curved has a slim, curved jaw that follows the natural contours of anatomy to help improve visibility and control, especially in tight or delicate areas. It also has a mechanical blade that cuts close to the tip, making it useful for dissecting tissue. With Vessel Sealer Curved, Intuitive Surgical, Inc. (NASDAQ:ISRG) aims to offer surgeons better precision in narrow anatomical spaces for a variety of procedures. Intuitive Surgical, Inc. (NASDAQ:ISRG) is an American medical device and technology company that develops and manufactures innovative, robotic-assisted systems for physicians and hospitals to make surgery less invasive. While we acknowledge the potential of ISRG as an investment, we believe certain AI stocks offer greater upside potential and carry less downside risk. If you're looking for an extremely undervalued AI stock that also stands to benefit significantly from Trump-era tariffs and the onshoring trend, see our free report on the best short-term AI stock. READ NEXT: 10 Best American Semiconductor Stocks to Buy Now and 11 Best Fintech Stocks to Buy Right Now. Disclosure: None. This article is originally published at Insider Monkey.
The Guardian
10-07-2025
- Health
- The Guardian
Robot surgery on humans could be trialled within decade after success on pig organs
Automated surgery could be trialled on humans within a decade, say researchers, after an AI-trained robot armed with tools to cut, clip and grab soft tissue successfully removed pig gall bladders without human help. The robot surgeons were schooled on video footage of human medics conducting operations using organs taken from dead pigs. In an apparent research breakthrough, eight operations were conducted on pig organs with a 100% success rate by a team led by experts at Johns Hopkins University in Baltimore in the US. The Royal College of Surgeons in the UK called it 'an exciting development that shows great promise', while John McGrath, a leading expert on robotic surgery in the UK, called the results 'impressive' and 'novel' and said it 'takes us further into the world of autonomy'. It opens up the possibility of replicating, en masse, the skills of the best surgeons in the world. The technology allowing robots to handle complex soft tissues such as gallbladders, which release bile to aid digestion, is rooted in the same type of computerised neural networks that underpin widely used artificial intelligence tools such as Chat GPT or Google Gemini. The surgical robots were slightly slower than human doctors but they were less jerky and plotted shorter trajectories between tasks. The robots were also able to repeatedly correct mistakes as they went along, asked for different tools and adapted to anatomical variation, according to a peer-reviewed paper published in the journal Science Robotics. The authors from Johns Hopkins, Stanford and Columbia universities called it 'a milestone toward clinical deployment of autonomous surgical systems'. Almost all the 70,000 robotic procedures carried out annually in the NHS in England were fully controlled under human instruction, with only bone-cutting for hip and knee operations semi-autonomous, McGrath said. Last month the health secretary, Wes Streeting, said increasing robotic surgery was at the heart of a 10-year plan to reform the NHS and cut waiting lists. Within a decade, the NHS has said, nine in 10 of all keyhole surgeries will be carried out with robot assistance, up from one in five today. In the Johns Hopkins trial, the robots took just over five minutes to carry out the operation, which required 17 steps including cutting the gallbladder away from its connection to the liver, applying six clips in a specific order and removing the organ. The robots on average corrected course without any human help six times in each operation. 'We were able to perform a surgical procedure with a really high level of autonomy,' said Axel Krieger, assistant professor of mechanical engineering at Johns Hopkins. 'In prior work, we were able to do some surgical tasks like suturing. What we've done here is really a full procedure. We have done this on eight gallbladders, where the robot was able to perform precisely the clipping and cutting step of gallbladder removal without any human intervention. 'So I think it's a really big landmark study that such a difficult soft tissue surgery is possible to do autonomously.' McGrath, who chairs NHS England's robotics steering committee, said autonomous surgery, while still years away, could one day lead to a human surgeon overseeing several autonomous robotic operations at the same time, carrying out simple procedures such as hernia operations or gall bladder removals more rapidly, with greater precision than humans and with less damage to surrounding bodily structures. But he cautioned that autonomous surgery remained a long way from being clinically deployable, because tests on dead pig organs do not test the robots' capacity to react to a patient moving and breathing, blood running in the field of operation, an inadvertent injury, smoke from cauterisation or fluid on the camera lens. Nuha Yassin, who leads on robotic surgery at the Royal College of Surgeons of England, said: 'The next step must involve a careful exploration of the nuances within this rapidly evolving field to assess how these findings can be safely and effectively translated into a human pilot. Only then can this approach move toward, becoming a sustainable model for the future.' She said training, education and patient safety must remain at the forefront.
The Independent
09-07-2025
- Health
- The Independent
Robot performs surgery with ‘100% accuracy'
A robot has performed realistic surgery on its own with 100% accuracy. The robot was watched as it performed a lengthy phase of a gallbladder removal on a life-like patient. It's been viewed as a 'major leap' towards using more robots in operating theatres. The robot operated with the expertise of a skilled human surgeon, according to Johns Hopkins University researchers in the US, even during unexpected scenarios typical in real-life medical emergencies. It was able to respond to and learn from voice commands from the team, just like a novice surgeon working with a mentor. Overall, there were 17 tasks in the surgery. The robot had to identify certain ducts and arteries and grab them precisely, strategically place clips, and sever parts with scissors. It was also able to adapt even when dye was introduced which changed the appearance of the organs and tissue. Associate professor in mechanical engineering, Axel Krieger, said: 'This advancement moves us from robots that can execute specific surgical tasks to robots that truly understand surgical procedures. 'This is a critical distinction that brings us significantly closer to clinically viable autonomous surgical systems that can work in the messy, unpredictable reality of actual patient care.' The work received federal government funding and was published in the journal Science Robotics. Back in 2022, a robot performed the first autonomous robotic surgery on a pig. However, it required specially marked tissue, operated in a highly controlled environment, and followed a rigid, pre-determined surgical plan. Mr Krieger said that phase was like teaching a robot to drive along a carefully mapped route. But the new system, he said, was 'like teaching a robot to navigate any road, in any condition, responding intelligently to whatever it encounters.' He added: 'To me it really shows that it's possible to perform complex surgical procedures autonomously.' The new system, which uses the same machine learning architecture that powers ChatGPT, also adapts to a patient's anatomical features in real-time and works to correct itself. It can respond to spoken commands such as 'grab the gallbladder head' or 'move the left arm a bit to the left', and then learns from that feedback. Ji Woong Kim, a former postdoctoral researcher at Johns Hopkins who is now at Stanford University, said: 'This work represents a major leap from prior efforts because it tackles some of the fundamental barriers to deploying autonomous surgical robots in the real world. 'Our work shows that AI models can be made reliable enough for surgical autonomy – something that once felt far-off but is now demonstrably viable.' Although the robot took longer to perform the work than a human surgeon, the results were comparable to an expert surgeon, researchers said. Next, the team will train and test the system on more types of surgeries. Reacting to the findings, Nuha Yassin, consultant colorectal surgeon and council member and lead for the future of surgery, robotics, and digital surgery at the Royal College of Surgeons of England (RCS England) said: 'It's always exciting to see new developments in surgical innovation, especially in areas like robotics and digital surgery. 'That said, the real test will be how safely and effectively the findings of this study can be translated into human trials. 'We need to make sure that progress doesn't come at the expense of patient safety. An additional focus is training our current and future generations as a whole, but also in technology and digital literacy. 'As interest in robotic and digital surgery continues to grow, we're committed to supporting that progress whilst focusing on safe implementation and training, through our guidance on robotic-assisted surgery and surgical innovation – while keeping equity of access and safety for our patients at the heart and centre.'
Yahoo
09-07-2025
- Health
- Yahoo
'Robotic surgery helped me back to the job I love'
A market stall holder has praised robot-assisted surgery for helping her get back to her customers sooner. Charlotte Gregersen, 62, underwent thoracic surgery at Royal Papworth Hospital in Cambridge to remove metastatic cancer in her right lung. The minimally invasive operation removed a piece of her right lung but meant she could leave hospital the next day - and return to her designer and vintage clothing stall at Cambridge market within a month. "The job I have is quite physical, so I had to make sure I recovered fully," she said. "I love working outside, I love my stall, and I've built up a good clientele that keep me busy." Ms Gregersen's cancer journey began nine years ago and has involved numerous hospital visits for different treatments. She was referred to Royal Papworth where her lung operation was carried out by a surgical team using the Versius surgical robot. She said: "[Mr Aman Coonar] explained that the robotic-assisted surgery would be minimally-invasive and lead to a quicker recovery time. "I had the operation through tiny incisions on the Monday and returned home on the Tuesday, which was very positive." Versius allows surgeons to make tiny incisions to work precisely inside the chest cavity, which can be seen in a magnified 3D view. Mr Coonar said the CMR robot meant patients "generally have little pain". "The system is also portable meaning it can be moved between theatres, which means more teams can use it," he added. "The system is improving all the time and our team is also getting slicker in its use. "As the NHS England national lead for thoracic surgery, I can say that our thoracic surgery teams are committed to improving the care for cancer patients. "We are also proud to be using British designed and British built technology." Royal Papworth became the first UK hospital to use Versius for thoracic surgery in 2023. Since then, surgical teams have used it to perform more than 250 minimally invasive procedures. Massimiliano Colella, chief executive of CMR Surgical said: "Versius was created to bring more patients the benefits of robotic assisted minimal access surgery, so we are delighted to see the tangible positive impact Versius has had for patients like Charlotte, including improved outcomes and quicker recovery times right here in Cambridge." Follow Cambridgeshire news on BBC Sounds, Facebook, Instagram and X. New treatment for heart valve disease in the east Seven lives saved in seven days at Royal Papworth 'Lungs in a box' could increase vital transplants Royal Papworth Hospital NHS Foundation Trust
